TrialSignal
Clinical trial intelligence report
Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin Versus Placebo in Burn Patients With Inhalation Trauma (Hepburn)
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT01773083
Status
TERMINATED
Phase
PHASE3
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Executive brief
Investment-Ready Snapshot
The trial aimed to evaluate the efficacy and safety of nebulized heparin compared to placebo in burn patients with inhalation trauma requiring mechanical ventilation. The study was terminated due to insufficient patient recruitment and high costs.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01773083
Indication
Inhalation Injury
Modality
small molecule
Target
Inhalation trauma in burn patients
Intervention
unfractionated heparin, placebo
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.